<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(3)</volume><submitter>Pachimsawat P</submitter><funding>Mahidol University</funding><pubmed_abstract>This study aimed to examine the effect of acute exogenous melatonin administration on salivary cortisol and alpha-amylase (sCort and sAA) as representatives of the HPA axis and the sympathetic nervous system, respectively. A single-dose prolonged-release melatonin (2 mg) or a placebo tablet was given to healthy volunteers (n = 64) at 20:00 h in a crossover design. The saliva was collected at six time points (20:00, 21:00, awakening, 30 min after awakening, 10:00, and 12:00 h) and was measured for sCort, sAA, and salivary melatonin (sMT) levels. Pulse rates and sleep parameters were also collected. Melatonin was effective in improving sleep onset latency by 7:04 min (p = .037) and increasing total sleep time by 24 min (p = .006). Participants with poor baseline sleep quality responded more </pubmed_abstract><journal>Pharmacology research &amp; perspectives</journal><pagination>e1205</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11103136</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exogenous melatonin's effect on salivary cortisol and amylase: A randomized controlled trial.</pubmed_title><pmcid>PMC11103136</pmcid><pubmed_authors>Jantaratnotai N</pubmed_authors><pubmed_authors>Pachimsawat P</pubmed_authors><pubmed_authors>Ratanachamnong P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exogenous melatonin's effect on salivary cortisol and amylase: A randomized controlled trial.</name><description>This study aimed to examine the effect of acute exogenous melatonin administration on salivary cortisol and alpha-amylase (sCort and sAA) as representatives of the HPA axis and the sympathetic nervous system, respectively. A single-dose prolonged-release melatonin (2 mg) or a placebo tablet was given to healthy volunteers (n = 64) at 20:00 h in a crossover design. The saliva was collected at six time points (20:00, 21:00, awakening, 30 min after awakening, 10:00, and 12:00 h) and was measured for sCort, sAA, and salivary melatonin (sMT) levels. Pulse rates and sleep parameters were also collected. Melatonin was effective in improving sleep onset latency by 7:04 min (p = .037) and increasing total sleep time by 24 min (p = .006). Participants with poor baseline sleep quality responded more </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-07-16T07:30:43.096Z</modification><creation>2026-07-09T10:43:16.803Z</creation></dates><accession>S-EPMC11103136</accession><cross_references><pubmed>38764237</pubmed><doi>10.1002/prp2.1205</doi></cross_references></HashMap>